Gabizon A - Search Results

1

What is the right way to administer pegylated liposomal doxorubicin in breast cancer therapy?

Grenader T, Gabizon A. Grenader T, et al. Among authors: gabizon a. J Clin Oncol. 2010 Apr 20;28(12):e193-4; author reply e195-6. doi: 10.1200/JCO.2009.26.8052. Epub 2010 Mar 1. J Clin Oncol. 2010. PMID: 20194839 No abstract available.

2

Long-term response to pegylated liposomal doxorubicin in patients with metastatic soft tissue sarcomas.

Grenader T, Goldberg A, Hadas-Halperin I, Gabizon A. Grenader T, et al. Among authors: gabizon a. Anticancer Drugs. 2009 Jan;20(1):15-20. doi: 10.1097/CAD.0b013e3283198058. Anticancer Drugs. 2009. PMID: 19342997

3

Monitoring long-term treatment with pegylated liposomal doxorubicin: how important is intensive cardiac follow-up?

Grenader T, Goldberg A, Gabizon A. Grenader T, et al. Among authors: gabizon a. Anticancer Drugs. 2010 Oct;21(9):868-71. doi: 10.1097/CAD.0b013e32833dc3c4. Anticancer Drugs. 2010. PMID: 20679886

4

Malignant epithelioid hemangioendothelioma of the liver successfully treated with pegylated liposomal doxorubicin.

Grenader T, Vernea F, Reinus C, Gabizon A. Grenader T, et al. Among authors: gabizon a. J Clin Oncol. 2011 Sep 1;29(25):e722-4. doi: 10.1200/JCO.2011.35.5891. Epub 2011 Jul 25. J Clin Oncol. 2011. PMID: 21788568 No abstract available.

5

BRCA mutation status and determinant of outcome in women with recurrent epithelial ovarian cancer treated with pegylated liposomal doxorubicin.

Safra T, Borgato L, Nicoletto MO, Rolnitzky L, Pelles-Avraham S, Geva R, Donach ME, Curtin J, Novetsky A, Grenader T, Lai WC, Gabizon A, Boyd L, Muggia F. Safra T, et al. Among authors: gabizon a. Mol Cancer Ther. 2011 Oct;10(10):2000-7. doi: 10.1158/1535-7163.MCT-11-0272. Epub 2011 Aug 11. Mol Cancer Ther. 2011. PMID: 21835933

6

Pharmacological basis of pegylated liposomal doxorubicin: impact on cancer therapy.

Gabizon A, Shmeeda H, Grenader T. Gabizon A, et al. Eur J Pharm Sci. 2012 Mar 12;45(4):388-98. doi: 10.1016/j.ejps.2011.09.006. Epub 2011 Sep 10. Eur J Pharm Sci. 2012. PMID: 21933707 Review.

7

Pegylated liposomal doxorubicin/carboplatin combination in ovarian cancer, progressing on single-agent pegylated liposomal doxorubicin.

Grenader T, Rosengarten O, Isacson R, Plotkin Y, Gabizon A. Grenader T, et al. Among authors: gabizon a. World J Clin Oncol. 2012 Oct 10;3(10):137-41. doi: 10.5306/wjco.v3.i10.137. World J Clin Oncol. 2012. PMID: 23198277 Free PMC article.

8

Dexrazoxane added to doxorubicin-based adjuvant chemotherapy of breast cancer: a retrospective cohort study with a comparative analysis of toxicity and survival.

Tahover E, Segal A, Isacson R, Rosengarten O, Grenader T, Gips M, Cherny N, Heching NI, Mesika L, Catane R, Gabizon A. Tahover E, et al. Among authors: gabizon a. Anticancer Drugs. 2017 Aug;28(7):787-794. doi: 10.1097/CAD.0000000000000514. Anticancer Drugs. 2017. PMID: 28562379

9

Combination therapy with oxaliplatin and 5-fluorouracil in a patient with severe hepatic dysfunction associated with metastatic adenocarcinoma of the large bowel.

Grenader T, Goldberg A, Gabizon A. Grenader T, et al. Among authors: gabizon a. Anticancer Drugs. 2009 Oct;20(9):845-7. doi: 10.1097/CAD.0b013e32832fd779. Anticancer Drugs. 2009. PMID: 19633535

10

Diethylstilbestrol for the treatment of patients with castration-resistant prostate cancer: retrospective analysis of a single institution experience.

Grenader T, Plotkin Y, Gips M, Cherny N, Gabizon A. Grenader T, et al. Among authors: gabizon a. Oncol Rep. 2014 Jan;31(1):428-34. doi: 10.3892/or.2013.2852. Epub 2013 Nov 14. Oncol Rep. 2014. PMID: 24247716

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters